These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14621384)

  • 1. [Undesirable effects of AIDS treatments].
    Tonnerre P; Delmotte H
    Rev Infirm; 2003 Oct; (94):12-5. PubMed ID: 14621384
    [No Abstract]   [Full Text] [Related]  

  • 2. Sweetening the toxic cocktail. Managing the side effects of HIV medications.
    Doerfler RE
    Adv Nurse Pract; 2002 May; 10(5):52-4, 57-8, 103. PubMed ID: 12420531
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of antiretroviral therapy--skin manifestations].
    Esser S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():8, 10-1. PubMed ID: 19024907
    [No Abstract]   [Full Text] [Related]  

  • 4. [The side effects of antiretroviral therapy].
    Hartmann M
    Hautarzt; 2006 Nov; 57(11):969-74. PubMed ID: 17036249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to minimize the secondary effects of antiretrovirals].
    Cernadas R
    Sidahora; 2003; (1):8-17. PubMed ID: 12733497
    [No Abstract]   [Full Text] [Related]  

  • 6. Double "d" drug danger.
    Moyle G
    AIDS Read; 2003 Jan; 13(1):15-6, 23-4. PubMed ID: 12569891
    [No Abstract]   [Full Text] [Related]  

  • 7. Appearance-related side effects of HIV-1 treatment.
    Hawkins T
    AIDS Patient Care STDS; 2006 Jan; 20(1):6-18. PubMed ID: 16426151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
    Introcaso CE; Hines JM; Kovarik CL
    J Am Acad Dermatol; 2010 Oct; 63(4):549-61; quiz 561-2. PubMed ID: 20846563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stop the assault on skin in HIV.
    Dulak SB
    RN; 2006 Jun; 69(6):25-9; quiz 30. PubMed ID: 16796269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Side effects of antiretroviral therapy].
    Teodor A; Teodor D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):23-6. PubMed ID: 15688751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving toxicities associated with anti-HIV therapies.
    Bean P
    Am Clin Lab; 2002 May; 21(4):12-5. PubMed ID: 12087632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stigmatization, metabolic trouble, drug resistance: current challenges in HIV therapy].
    Mauss S; Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):28. PubMed ID: 19769068
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
    Moyle G; Carr A
    HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of metabolic complications after 10 years of antiretroviral treatment in Senegal].
    Diouf A; Cournil A;
    Bull Soc Pathol Exot; 2014 Oct; 107(4):234-7. PubMed ID: 24683016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Side effects of treatment with sulfones].
    Revuz J; Hornac P
    LARC Med; 1981 Dec; 1(3):68-70. PubMed ID: 6298511
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-associated lipoatrophy: what are the kinder, gentler agents?
    Dubé MP
    Clin Infect Dis; 2006 Jan; 42(2):281-2. PubMed ID: 16355342
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV and insulin resistance in context.
    Kotler DP
    AIDS Read; 2005 May; 15(5):220. PubMed ID: 15900630
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome.
    Guzmán-Fulgencio M; Micheloud D; Lorente R; Bellón JM; Gomez MI; Gurbindo MD; León JA; Muñoz-Fernández MÁ; Resino S
    J Infect; 2011 Mar; 62(3):240-3. PubMed ID: 21256862
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV and AIDS in inpatient dermatology. Approach to the consultation.
    Finkelstein M; Berman B
    Dermatol Clin; 2000 Jul; 18(3):509-20, x. PubMed ID: 10943545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
    van Griensven J; Zachariah R; Rasschaert F; Mugabo J; Atté EF; Reid T
    Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):148-53. PubMed ID: 19732926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.